Navigation Links
Patti Flint MD, A Top Female Plastic Surgeon in the Southwest, Is Proud To Offer Cutting-Edge 3D Crisalix Technology to Patients When Selecting Breast Implants

Scottsdale and Mesa, Arizona, USA (PRWEB) April 22, 2013

Dr. Patti Flint, a six-time Top Doc of Phoenix award winner, is a board certified plastic surgeon in practice since 1996. She has completed over 8000 plastic surgery procedures. Her medical training was obtained at Baylor College of Medicine and University of Texas at Houston. She specializes in cosmetic surgery of the breast, body and face. Visit her comprehensive website at

When someone thinks about modifying their physical aspect, seeing the outcome beforehand is essential. Already for a simple act of choosing new clothes, one is used to trying on before buying. It is therefore understandable that only once a person has seen a 3D simulation answering the question “how could I look after the procedure?” that they can properly imagine and understand the change they are contemplating.

Crisalix is the world’s first web-based 3D simulator for aesthetic procedures which recreates in 3D the patient’s face or body using three standard 2D photos that the patient uploaded from the comfort of their home. The 3D images are generated by Crisalix and sent to the doctor before the patient even comes to the clinic to enable accurate pre-visualizations of the final result of the procedure during the consultation.

The surgeon can concentrate exclusively on understanding and clarifying the patient’s desires and expectations, without spending precious time taking photos or preparing the 3D images. The patient can actively participate in the process of generating the 3D images and seeing their new face or body in 3D, as opposed to imagining the result using traditional methods, such as photos of other patients that do not represent the patient’s own anatomy.

This breakthrough technology, now offered by Dr. Flint, increases patient education, understanding and interaction, to further optimize in-consultation and post-procedure satisfaction.

What do patients and the world’s top plastic surgeons say about Crisalix?

A recent study carried out in Switzerland on patients who had breast augmentation between 2011 and 2012 and who saw Crisalix 3D simulations of their new body during pre-surgery consultations showed that 87.5% felt Crisalix allowed them to express their desires and expectations and all were either satisfied or very satisfied with the 3D images.

“This is a fantastic revolution for the patient as well as for the surgeon. For the patient, there is nothing like seeing simulations of her own body. This technology should help all surgeons, from novice to advanced, in establishing realistic patient expectations and improving results. "
Prof. Jan Poell, Plastic Surgeon, Former President of the International Society of Aesthetic Plastic Surgery

Crisalix’s technology recommended by the world’s leading federation in this field

IPRAS, the leading international federation for Plastic Surgery, recommends Crisalix ( for the significant progress its 3D simulation technology brings to the entire medical community, along with its contribution to patient education and a more informed decision-making process. Patients using Crisalix have demonstrated much higher levels of satisfaction, corresponding directly to IPRAS’ objectives in improving the care and treatment of every patient seeking plastic surgery.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. "O-Shot™" May Improve Female Sexual Response
2. Palatin Technologies Reports Positive Results for Phase 2B Bremelanotide Female Sexual Dysfunction Trial
3. Eppendorf Video Features Dr Andrew Holts Work on Bioactive Leachates From Plastic Consumables
4. New HydraSolve™ Lipoplasty System launched at American Society of Aesthetic Plastic Surgery Meeting
5. Study of Cell Therapeutics Tosedostat for Elderly Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome Now Enrolling
6. DNA2.0 Patents Key Method for Synthesizing Bioplastic Polymer
7. Dr. Michael Yaremchuk, Leading Performer of Custom-Designed Facial Implants, Pioneers Bespoke Plastic Surgery
8. Dr. Peter C. Neligan, Author of 3rd Edition of Elseviers Plastic Surgery Text, Available for Comment on the Contributions of Dr. Joseph Murray
9. Lucintel’s Analysis of the Global Glass Mat Thermoplastics Industry: Market is Expected to Reach US $481 Million in 2017
10. New UV Plastic Disposable Cuvettes
11. Lucintel Report Outlines Significant Growth Opportunities for Continuous Fiber Thermoplastic Industry Players During 2012-2017
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... ... were featured on AngelList early in their initial angel funding process. Now, they ... for individuals looking to make early stage investments in the microbiome space. ...
(Date:11/24/2015)... Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be ... York on Wednesday, December 2 at 9:30 a.m. ET/6:30 ... CEO, will provide a corporate overview. th Annual ... 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola , ... corporate overview. --> th Annual Oppenheimer Healthcare Conference ...
(Date:11/24/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) (the ... the Toronto Stock Exchange, confirms that as of the ... developments that would cause the recent movements in the ... --> About Aeterna Zentaris Inc. ... Aeterna Zentaris is a specialty biopharmaceutical company engaged in ...
(Date:11/24/2015)... , ... November 24, 2015 , ... The Academy of ... Interest Group (SIG), MultiGP, also known as Multirotor Grand Prix, to represent the First–Person ... few years. Many AMA members have embraced this type of racing and several new ...
Breaking Biology Technology:
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
(Date:10/29/2015)... , Oct. 29, 2015  The J. Craig ... report titled, "DNA Synthesis and Biosecurity: Lessons Learned and ... Department of Health and Human Services guidance for synthetic ... 2010. --> --> ... also has the potential to pose unique biosecurity threats. ...
(Date:10/29/2015)... ARBOR, Mich. , Oct. 29, 2015 /PRNewswire/ ... Eurofins Genomics for U.S. distribution of its DNA ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq kit. ... to enable the preparation of NGS libraries for ... plasma for diagnostic and prognostic applications in cancer ...
Breaking Biology News(10 mins):